Fundz

Vis Cardia, Inc. reported raising $1.5 Million in an initial SEC Form D filing, from an offering of $2.7 Million

PRIVATEApr 05, 2022$1.5M of $2.7M raised

Amount Raised

$1.5 Million

$1.5 Million sold, per SEC Form D (first sale Apr 5, 2022)

Round Type

Seed

BeavertonInformation Technologymedical devices

Quick answer

VisCardia raised $1.5 Million in a Seed round, dated April 5, 2022. VisCardia is based in Beaverton, Oregon, United States.

How much did VisCardia raise?
VisCardia raised $1.5 Million in a Seed round on April 5, 2022.
What does VisCardia do?
VisCardia Inc is a privately held medical device company in Portland Oregon developing a novel chronic heart failure therapy.
Where is VisCardia based and how big is it?
VisCardia is based in Beaverton, Oregon, United States. Fundz records about 8 employees.
Who are the decision-makers at VisCardia?
Fundz holds 2 contacts at VisCardia, including the President. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in medical devices around the same time

Companies in the same sectors as VisCardia that raised within 45 days of this round, from Fundz verified event records.

  • Qure.ai raised $40M (Funding Round) on March 29, 2022.

Who to call at VisCardia, and when

A new round usually means VisCardia is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day VisCardia raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at VisCardia, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at VisCardia. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

VisCardia

Location

8770 SW Nimbus Avenue, Suite D

Beaverton, Oregon, United States

About

VisCardia Inc is a privately held medical device company in Portland Oregon developing a novel chronic heart failure therapy. The VisOne implantable system delivers Synchronized Diaphragmatic Stimulation (SDS) which generates transient intrathoracic pulses gaited to cardiac activity and augments cardiac hemodynamics.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment VisCardia raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsPeter B., President hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for VisCardia's next move

See what Strategic adds

VisCardia raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.